Kala Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 11/05/20
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference CallBusiness Wire • 10/29/20
Kala Pharmaceuticals Announces FDA Approval of EYSUVIS™ for the Short-Term Treatment of the Signs and Symptoms of Dry Eye DiseaseBusiness Wire • 10/27/20
Is the Options Market Predicting a Spike in Kala Pharmaceuticals (KALA) Stock?Zacks Investment Research • 10/08/20
Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™Business Wire • 09/10/20
Kala Pharmaceuticals to Present at Upcoming Investor Conferences in SeptemberBusiness Wire • 09/08/20
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20
Kala Pharmaceuticals (KALA) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/06/20
Kala Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate UpdateBusiness Wire • 08/06/20
Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual ConferenceBusiness Wire • 08/04/20
Kala Pharmaceuticals to Report Second Quarter 2020 Financial Results and Host Conference CallBusiness Wire • 07/30/20
Kala Pharmaceuticals (KALA) May Report Negative Earnings: Know the Trend Ahead of Q2 ReleaseZacks Investment Research • 07/28/20
Is Kala Pharmaceuticals (KALA) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 06/05/20
Has Kala Pharmaceuticals (KALA) Outpaced Other Medical Stocks This Year?Zacks Investment Research • 05/19/20
Kala Pharmaceuticals, Inc. (KALA) CEO Mark Iwicki on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
Kala Pharmaceuticals (KALA) Is Up 2.56% in One Week: What You Should KnowZacks Investment Research • 05/05/20
Here's Why Momentum Investors Will Love Kala Pharmaceuticals (KALA)Zacks Investment Research • 04/16/20
Is Kala Pharmaceuticals (KALA) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 03/10/20